15th Annual Biotech in Europe Forum for Global Partnering & Investment29th - 30th September 2015 | Congress Center Basel | Switzerland

Public Markets and M&A - Room BostonChaired by: Stephanie Léouzon, Principal and Head, Torreya Partners (Europe), LLCPanellists:Jim Phillips, CEO, Midatech Pharma PLCJim Steel, Head of Healthcare and Life Sciences, Corporate Finance, Peel Hunt LLPNicholas Franco, EVP & CBDO, Actelion Pharmaceuticals Ltd.Peter Homberg, Partner/Lawyer, Dentons Europe, LLCRudi Pauwels, CEO, Biocartis NVVivek Ramaswamy, CEO, Axovant SciencesInvestors & Analysts - Room BostonChaired by: Bob Pooler, Sr. Healthcare Analyst, valuationLAB AGPanellists:Chris Marai, Executive Director, Oppenheimer & Co.Christian Lach, Portfolio Manager, Analyst, Bellevue Asset Management AGDaniel Anizon, Financial Analyst, Independent ConsultantIvo Staijen, CFA, HBM Partners AGStephen Brozak, Managing Partner and President, WBB Securities, LLC

Personalised Medicine & Diagnostics - Room DelhiCo-Chaired:Alain Huriez, Partner, Advent Life SciencesRainer Metzger, VP Global Business Development Pharma, QIAGEN GmbHPanellists:Anish Bhatnagar, President and CEO, Capnia, Inc.Bill Mullen, CEO, Momentum Bioscience Ltd.Eduardo Margallo, CEO, MedLumics S.L.João Pereira, CEO, MagnomicsMiro Venturi, Global Head, Diagnostics Biomarkers, F.Ho�mann La Roche AGStephen Zaniboni, CFO, Trovagene, Inc.

Raising Capital Outside Europe - BostonChaired by: Beth Jacobs, Managing Partner, Excellentia Global PartnersPanellists:Adam Kostyál, Senior Vice President, Nasdaq OMXChris Maggos, Managing Director, Europe, LifeSci AdvisorsDavid Stueber, Managing Director, BNY MellonSaad Gilani, Managing Director & Head of Healthcare Investments, Yorkville Advisors, LLCThomas Stockman, Director, Healthcare Investment Banking, RBC

Vaccines - Room DelhiCo-Chaired:Chris Britten, Managing Director, Torreya Partners (Europe), LLCFlorian Schödel, Owner, Philimmune, LLCPanellists:Je� Baxter, CEO, VBI VaccinesJoel Crouzet, CEO & CSO, InnaVirVaxKatherine Cohen, CEO, Hookipa Biotech AGOliver Siegel, CEO, AFFiRiS AGRonald Kempers, President and CEO, Mymetics Corporation

Re-Pharm Ltd.

Rebiotix, Inc.

Pharmaco-KinesisCorporation

CEVEC Pharmaceuticals GmbH

Selexis SA

Pantec Biosolutions AG

Hansa Medical AB

Presentation Track A - Room DarwinModerated by: Oliver Haslam

Presentation Track B - Room LimaModerated by: Lorenza Castellon

08:00 Registration & Co�eeWelcome Speech by Beth Jacobs, Managing Partner, Excellentia Global Partners - Room Boston08:15

08:30

10:00

Co�ee Break

09:15

08:45

09:45

09:0009:00

09:10

09:20

09:30

09:40

09:50

10:00

10:10

10:20

10:30

09:15

09:30

09:45

10:00

10:15

10:30

Minoryx Therapeutics S.L.

Genkyotex S.A.

Rexahn Pharmaceuticals, Inc.

Randox Biosciences

PNBDevCo

Gabather AB

Autifony Therapeutics Ltd.

Athera Biotechnologies AB

Abionic SA

Magnomics

10:45

Companion Diagnostics Development

For Wi-Fi please connect Sachs Forum Wi-FiUserID: 2253442706Password: 4669

Late Stage Investment - Room BostonChaired by: Genghis Lloyd-Harris, Partner, Abingworth LLPPanellists:Arthur Franken, Partner, Gilde Healthcare PartnersCarole Nuechterlein, Head, Roche Venture FundDeborah Harland, Partner, S.R. One Ltd.Joshua Resnick, President, MRL VenturesMarkus Goebel, Partner, Novartis Venture FundMarkus Hosang, General Partner, BioMedPartners AGNaveed Siddiqi, Partner, Edmond de Rothschild Investment Partners

Orphan & Rare Diseases - Room DelhiChaired:Detlev Mennerich, Investment Manager, Boehringer Ingelheim Venture Fund GmbHPanellists:Charlie Alexander, Lead-BD Transactions, Shire PharmaceuticalJutta Roth, Business Development Manager, University of OxfordMarc Martinell, Chief Executive O�cer, Minoryx Therapeutics S.L.Mark Pykett, CEO, Agilis Biotherapeutics, LLCNanna Lüneborg, Investment Director, Novo A/SStephen Helliwell, Senior Investigator, Novartis Institutes for BioMedical Research

Early Stage Investment - Room BostonChaired by: Nooman Haque, Director of Life Sciences, Silicon Valley BankPanellists:Barbara Domayne-Hayman, CBO, Autifony Therapeutics Ltd.Bernd Goergen, Investment Director, High-Tech Gruenderfonds Management GmbHBill Blair, Head of Business Creation, Edinburgh BioQuarterCarina Schmidt, CEO, Athera Biotechnologies ABHakan Goker, Senior Investment Director, MS VenturesSøren Møller, Managing Investment Director, Novo A/S

15th Annual Biotech in Europe Forum for Global Partnering & Investment29th - 30th September 2015 | Congress Center Basel | Switzerland

11:20

11:00

11:00

12:00

Addex Therapeutics Ltd.

Isarna Therapeutics GmbH

Flexion Therapeutics

Achelios Therapeutics, Inc.

KineMed, Inc.

Heptares Therapeutics

Probiodrug AG

Axovant Sciences

Presentation Track C - Room DarwinModerated by: Robin Davison

Presentation Track D - Room LimaModerated by: Tomas Kahn

11:0011:00

11:10

11:20

11:30

11:40

11:50

11:15

11:30

11:45

12:00

12:15

12:30

12:45

12:00

12:15

12:30

12:45

Anagenesis Biotechnologies

eTheRNA

Acousia Therapeutics GmbH

Therabron Therapeutics

Mymetics Corporation

InnaVirVax

AFFiRiS AG

Tonix PharmaceuticalsHolding Corp.

Hookipa Biotech AG

VBI Vaccines

13:00 Networking Lunch

12:20

Interview by Fintan Walton, CEO, PharmaVentures Ltd. - Room BostonJason Coloma, Head of Oncology and Cancer Immunology, Roche Partnering, F. Ho�mann La Roche AG

Platform Technologies & Novel Therapeutics - Room Delhi Co-Chaired by: David Colpman, Director, Colpman Consulting Ltd.David Phillips, Partner, S.R. One Ltd.Panellists: Chris Moriarty, Global Manager, Pharma Sciences Division, Randox BiosciencesElias Papatheodorou, CBO, Genkyotex S.A.Geert Cauwenbergh, President and CEO, RXi Pharmaceuticals CorporationMaarit Merla, Head of Business Development, Forendo Pharma Ltd.Melya Hughes Crameri, Head of BD, Europe, Amunix Operating Inc. Philippe Calais, CEO, Isarna Therapeutics GmbHVikas Sharma, Director, BD, Rexahn Pharmaceuticals, Inc.

15th Annual Biotech in Europe Forum for Global Partnering & Investment29th - 30th September 2015 | Congress Center Basel | Switzerland

14:00

Cell and Gene Therapies: Recent Advances - Room BostonCo-Chaired by: Christian Glennie, Head of Research, Healthcare, Edison Investment ResearchRao Movva, Novartis Distinguished Scientist / Scout-Collaborations, Novartis Institutes for BioMedical ResearchPanellists:Martin McGlynn, President & CEO, StemCells, Inc.Matthew Durdy, CBO, Cell Therapy CatapultPedro Lichtinger, CEO, Asterias BiotherapeuticsPeter Nolan, CBO, Oxford Biomedica Ltd.Stéphane Boissel, CEO, TxCell SAWim Jongen, CEO, Glycostem Therapeutics

14:00 Abzena PLC

AcelRx Pharmaceuticals, Inc.

Aptose Biosciences, Inc.

MISSION Therapeutics Ltd.

Immune Pharmaceuticals, Inc.

Galena Biopharma, Inc.

Presentation Track E - Room DarwinModerated by: Daniel Gooch

Presentation Track F - Room LimaModerated by: Wilder Fulford

14:00

14:15

14:30

14:45

15:00

15:15

Infectious Diseases - Room DelhiChaired by: Laurenz Kellenberger, CSO, Basilea Pharmaceutica Intern.Panellists: B. Chandler May, President and CEO, In�ammatory Response Research, Inc.Marc Gitzinger, CEO and Co-Founder, BioVersys AGMatt Adams, VP Tech Ops and Business Development, Rebiotix, Inc.Nicholas Benedict, CEO & Co-Founder, Allecra Therapeutics

CV & Metabolic Diseases - Room DelhiChaired by: Christoph Pittius, VP, Head of Transactions, BD, AstraZeneca ABPanellists: Eckhard Leifke, VP External Opportunities CV & Metabolism, Sano�Harold Van Wart, President and CEO, Director, CymaBay TherapeuticsJohannes Zanzinger, Global Head, BD & Licensing Cardiometabolic Diseases, Boehringer Ingelheim Pharma GmbH & Co. KG

Capnia, Inc.

Midatech Pharma PLC

Trovagene, Inc.

Agilis Biotherapeutics, LLC

Numab AG

RXi Pharmaceuticals, Corp.

14:00

14:15

14:30

14:45

15:00

15:15

Co�ee Break15:30

14:45

Interview by Fintan Walton, CEO, PharmaVentures Ltd. - Room BostonSusan Herbert, EVP, Head of Global BD & Alliance Management, Merck KGaA

“Rescuing Drugs: A New Strategy For Addressing Unmet Medical Need” Vivek Ramaswamy, CEO, Axovant Sciences15:45 15:45

16:05

16:15

16:30

16:45

-

WuXi AppTech, Inc.

Theradex (Europe) Ltd.

Neuroscience & Pain I - CNS - Room DelhiChaired by: Klaus Mendla, Global Head, BD & Licensing CNS, Boehringer Ingelheim Pharma GmbH & Co. KGPanellists: Erik Buntinx, Founding CEO, PNBDevCoHendrik Liebers, CFO, Probiodrug AGMalcolm Weir, Co-Founder and CEO, Heptares TherapeuticsPatrick Doyle, President, KineMed, Inc.Tim Dyer, CEO, Addex Therapeutics Ltd.

Asterias Biotherapeutics

Glycostem Therapeutics

Oxford BioMedica PLC

StemCells, Inc.

15:45

16:00

16:15

16:30

Presentation Track H - Room LimaModerated by: Beth Jacobs

15:45

15:55

16:05

16:15

16:25

InDex Pharmaceuticals AB

BioVersys AG

Allecra Therapeutics

In�ammatory ResponseResearch, Inc.

ObsEva SA

16:35 TocopheRX, Inc.

Presentation Track G - Room DarwinModerated by: Joergen Thorball

SPACE FOR NOTES:

16:40

Neuroscience & Pain II - PAIN - Room DelhiChaired by: Fabrizio Gasparini, Director, Novartis Institutes for BioMedical ResearchPanellists: Crist Frangakis, CEO and President, Achelios Therapeutics, Inc. Leland Gershell, CFO, Tonix Pharmaceuticals Holding Corp.Masa Yuhara, General Manager, BD, Mitsubishi Tanabe Pharma Europe Ltd.Rahul Ballal, Director, BD, Flexion TherapeuticsTimothy Morris, CFO, Head of BD, AcelRx Pharmaceuticals, Inc.

15th Annual Biotech in Europe Forum for Global Partnering & Investment29th - 30th September 2015 | Congress Center Basel | Switzerland

17:00

Academic Collaborations & Tech Transfer - Room BostonCo-Chaired by: Edwin Constable, Head of Research, Professor of Chemistry at the University of Basel and Project leader and Member of the Management Board within the SNILuc Otten, Business Development, Alpine Institute for Drug DiscoveryPanellists: Jana Watson-Capps, Associate Director, University of Colorado BioFrontiers InstituteLars Gredsted, Senior Business Analyst, Wellcome TrustLaura Lane, Business Development Manager, Warwick Ventures Ltd.Maria Hassard, Deputy Director of Research & Development, Moor�elds Biomedical Research CentreNicola Thompson, Head, O�ce of External Drug Discovery, F. Ho�mann La Roche AGPascale Auge, CEO, Inserm Transfert

17:15

Autoimmune & In�ammatory - Room Delhi Co-Chaired by: Jane Atkins, Director, Search & Evaluation, Centre for External Innovation, Takeda Pharmaceuticals International GmbHLubor Gaal, Head of Licensing and External Innovation, Almirall S.A.Panellists:Celia Zinger, Director Medical A�airs, Immune Pharmaceuticals, Inc.Kia Motesharei, Head of Global Licensing & BD, Immunology, EMD SeronoNathalie ter Wengel, Director of Business Development, GalapagosPeter Zerhouni, CEO, InDex Pharmaceuticals ABSimon Blake, Sr. Director, Scienti�c Licensing for Immunology, J&JThomas Hanke, EVP Immunology & In�ammation, Evotec International GmbH

ContinuedPresentation Track G - Room DarwinModerated by: Joergen Thorball

TxCell SA

CymaBay Therapeutics

Michelson Diagnostics Ltd.

Biophytis

Syna�x BV

16:45

17:00

17:15

17:30

17:45

ContinuedPresentation Track H - Room LimaModerated by: Beth Jacobs

16:45

16:55

17:05

17:15

17:25

Saphetor

MedLumics S.L.

Aptahem AB

TBC

Forendo Pharma Ltd.

17:35

17:45

TBC

TBC

18:00 End of Day One

19:00 Networking Reception at the Grand Hotel “Les Trois Rois” sponsored by Kanton Basel-Stadt

21:00 End of Reception

15th Annual Biotech in Europe Forum for Global Partnering & Investment29th - 30th September 2015 | Congress Center Basel | Switzerland

08:00 Registration & Co�ee

09:00

Partnering I – Early Stage - Room BostonCo-Chaired by: Chris Britten, Managing Director, Torreya Partners (Europe) LLPFintan Walton, CEO, PharmaVentures Ltd.Panellists:Iain Dukes, SVP Business Development & Licensing, Merck Research Laboratories Loic Vincent, Head, Oncology External Innovation, Sano�Maria Flocco, Senior Director, Head Strategic Research, P�zerAnand Gautam, Director, R&D Innovation Sourcing, Novo Nordisk A/STim Luker, Senior Director, External Innovation, Corporate Business Development, Eli Lilly & CompanyShane Maloney, Business Development Director, AstraZeneca

10:00

Partnering II – Late Stage - Room BostonCo-Chaired by: Chris Britten, Managing Director, Torreya Partners (Europe) LLPFintan Walton, CEO, PharmaVentures Ltd.Panellists:Donnie Mcgrath, Vice President Business Development, Bristol-Myers SquibbFrederic Desdouits, Head of Corporate BD & Acquisitions, Pierre FabrePhilippe Lopes-Fernandes, Senior Vice-President, Head of Global Licensing & Business Development, MERCK Serono / EMD Serono, Inc.

10:45 Co�ee Break

NanobiotixTBA

Amunix Operating, Inc.

MiNA Therapeutics

TREEWAY BV

Cell Therapy Ltd.

4D Lifetec AG

Genclis SAS

ViraTherapeutics GmbH

Microbial Robotics

Takis S.r.l.

Oryx GmbH & Co. KG

Metys Pharmaceuticals AG

ImmunID

Prophylix Pharma, Inc.

Oryzon Genomics

Presentation Track A - Room DarwinModerated by: Tomas Kahn

09:00

09:15

09:30

09:45

10:00

10:15

10:30 TBA

Presentation Track B - Room LimaModerated by: Joergen Thorball

09:00

09:10

09:20

09:30

09:40

09:50

10:00

10:10

10:20

10:30

15th Annual Biotech in Europe Forum for Global Partnering & Investment29th - 30th September 2015 | Congress Center Basel | Switzerland

11:00

Oncology I – Early Stage - Room BostonChaired by: Tim Herpin, Head of Transactions team, AstraZeneca ABPanellists: Austin Smith, Medical Director, Theradex (Europe) Ltd.Bernhard Sixt, CEO, ImmunIDBernard Bihain, CEO, Genclis SASBernard Huber, Chief Executive O�cer and Founder, Oryx GmbH & Co. KGProf. Dorothee Holm-von Laer, Co-founder and CEO, ViraTherapeutics GmbHMichael Scherz, Founder & CEO, Metys Pharmaceuticals AG

12:00

Oncology II – Advanced Technologies - Room BostonCo-Chaired by: Ekaterina Smirnyagina, Partner, Capricorn Venture Partners Panellists: Carlos Buesa, CEO, Oryzon Genomics Clive Stanway, CSO, Cancer Research Technology Ltd.Paul Rennert, Founder & Principal, SugarCone Biotech LLCStephen Sands, Commercial Lead Oncology/Immunology, F. Ho�mann-La Roche AGGaudenz von Capeller, CFO, PIQUR Therapeutics AG

13:00 Networking Lunch

14:00

Oncology III – Pharma/Biotech BD&L - Room BostonCo-Chaired by: François Thomas, Managing Director, Thomas Conseil SPRLPeter Hoang, Senior Vice President, Business Development & Strategy, Bellicum Pharmaceuticals, Inc.Panellists:David Meininger, Senior Vice President Business Development, OncoSec Medical, Inc.Georg Buchner, Licencing Director Europe, Amgen, Inc. Loic Vincent, Head, Oncology External Innovation, Sano�

15:00 Interactive Workshop by Nigel Borshell, Vice President, PharmaVentures Ltd. - Room Boston“Founder’s equity – Dilute to taste! …Exploring participants’ intuitive feelings for value around early stage company equity splits in a developing case history based scenario.”

16:30 Last Chance to Network

17:00 End of the Forum

Cristal Therapeutics

Nordic Nanovector ASA

OncoSec Medical, Inc.

Provectus Biopharmaceuticals, Inc.

TBA

TBA

SurgiMab SAS

ArmaGen, Inc.

TheraSolve NV

Plant Advance Technologies PAT

Eyevensys

Atriva Therapeutics GmbH

Haemostatix Ltd.

Available

Available

Available

Available

Available

Available

Available

Presentation Track C - Room DarwinModerated by: Hans Herklots

11:00

11:15

11:30

11:45

12:00

12:15

12:30

12:45

Presentation Track D - Room LimaModerated by: Lorenza Castellon

11:00

11:10

11:20

11:30

11:40

11:50

12:00

12:10

12:20

12:30

12:40

12:50

For Wi-Fi please connect Sachs Forum Wi-FiUserID: 2253442706Password: 4669